Marijuana Toxicology Presentation
Marijuana usage is ubiquitous and growing, but not without consequences. Whatever your practice, marijuana may be involved. View the presentation delivered at PACDL DUI & Motor Vehicle Summit on February 11, 2022 (PDF, 42 slides)
Contrast Media Toxicity Case Reports
We have been consulted in numerous interesting cases that demonstrate that even drugs deemed generally safe for use can show serious side effects if certain factors go wrong.
If the drug dosing is incorrect, if the drug is not administered properly, if too much drug is given (overdose),
Marijuana in Injury Litigation: The New Alcohol
Medical Marijuana is legal in at least 2 dozen states and the approved indications are increasing. Recreational marijuana is legal in only a few, but more are to follow. Even without legal status, marijuana use is widespread, and with legalization, use will increase.
As forensic consultants, we have consulted on marijuana matters in a wide variety of civil and criminal matters, similar to our consultations in alcohol. Legal or not, if an event occurs, or a person is injured and marijuana use is suggested or detected, part of the focus will be on marijuana.
The attached lecture PPT addresses this matter and provides some case examples that may be useful or interesting.
Forensic analysis of adverse drug events and litigation claims in ob/gyn
Injury is a risk/complication of any drug therapy, and more damaging to the patient and the caregiver if the drug was selected, administered, dispensed, or monitored negligently, contributing greatly to the injury. Obstetrical patients are at even greater risk, given the little known teratologic and embryo-fetal toxicity of drugs given during pregnancy and the perinatal period.
The facts and outcomes of the following Obstetric litigation cases will be presented and discussed:
Fatal electrolyte disturbance in hyperemesis gravidum
Pharmacy & Therapeutics Article $20 Million Verdict in Drug interaction case
Pharmacy & Therapeutics Article $20 Million Verdict in Drug interaction case
Preface to “Drug Injury, Liability, Analysis and Prevention. Third Edition.”
Drug Injury, Liability, Analysis, and Prevention, Third Edition (2012) was designed to serve as a reference for attorneys, pharmacists, physicians, risk managers, nurses, drug manufacturers, and regulators—as well as anyone with any interest in drug use and drug injury. It summarizes the FDA’s responsibility in monitoring dr ug development and safety. It reviews current drug-product-related liability issues that focus on the manufacturer’s role in providing for drug safety. The book identifies important roles that pharmacists play in enhancing medication safety and effectiveness, and demonstrates what can happen when pharmacists and other practitioners and healthcare institutions do not perform adequately. By focusing on the most dangerous drugs, the reader can learn from the tragedies and mistakes of others, look at their own practice settings, and avoid making similar mistakes.
Transitions of Care. Pitfalls and Recommendations
Transitions of CareBy James O’Donnell, PharmD, MS; and F. Randy Vogenberg, RPh, PhD.P&T 2012;37(12):679-682.Discusses the risk of prescription transcription errors resulting from the transition of patients to different levels of care. (PDF Format)